The ADC was associated with an overall response rate of 27%, all partial responses showing tumour shrinkage, and a disease control/tumour stabilisation rate of 85%.

The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...

In this article, we are going to take a look at where Agree Realty Corporation (NYSE:ADC) stands against the other stocks that pay monthly dividends. Dividend stocks have long been a favorite ...

This resignation was contained in a letter dated December 8, which was addressed to Chief Okey Nwosu, National Chairman of ADC. According to him, his resignation was hinged on a mismatch of ...

PMCC_XCM_64x64_D IP block is a low-power array of 1GHz clocked Cross-Correlator cells that are synchronously acquiring two sets of 64x2-bit data streams which are derived by digitizing IF signals at a ...

Duality Biologics has shared the first data from a phase 1/2a antibody-drug conjugate (ADC) trial, giving an early look at how the BioNTech-partnered asset is shaping up against rival molecules in ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the ...

Suven Pharma has acquired a majority stake in NJ Bio, marking a strategic expansion into the Antibody-Drug Conjugates (ADC) sector. Vivek Sharma of Suven Pharma, emphasized that this acquisition ...

LTD. (HANGZHOU DAC), a global leader in ADC innovation. Per the terms of the license agreement, Aadi is granted exclusive rights to certain patents and know-how pertaining to three preclinical ADC ...

As­traZeneca and Dai­ichi Sankyo have un­veiled new da­ta on their TROP2-di­rect­ed ADC in pre­treat­ed lung can­cer pa­tients with EGFR-mu­tat­ed dis­ease, adding to their case for … ...